Table 2.

Alternative antigen expression in antigen-positive and antigen-negative tumors

Melan-A (n = 596)
gp100 (n = 596)
Tyrosinase (n = 596)
NY-ESO-1 (n = 596)
MAGE-1 (n = 596)
MAGE-4 (n = 596)
+ (557)− (29)+ (545)− (41)+ (557)− (29)+ (270)− (316)+ (217)− (369)+ (170)− (416)
Melan-A557 (100)0 (0)540 (99)17 (41)551 (99)13 (45)262 (97)297 (94)211 (97)347 (94)160 (94)399 (96)
gp100540 (97)5 (18)545 (100)0 (0)540 (97)9 (32)254 (94)291 (92)204 (94)354 (96)156 (92)391 (94)
Tyrosinase546 (98)7 (25)534 (98)19 (46)557 (100)0 (0)262 (97)293 (93)208 (96)347 (94)160 (94)395 (95)
NY-ESO-1262 (47)9 (32)256 (47)15 (36)262 (47)8 (29)270 (100)0 (0)148 (68)122 (33)114 (67)154 (37)
MAGE-1206 (37)7 (25)191 (35)15 (36)206 (37)8 (29)146 (54)70 (22)217 (100)0 (0)134 (79)79 (19)
MAGE-4162 (29)12 (40)158 (29)14 (33)162 (29)10 (36)116 (43)57 (18)137 (63)37 (10)170 (100)0 (0)
  • NOTE: All tumors have been designated as positive or negative for each of the six antigens (columns). The presence of each of the remaining five antigens was determined (rows), and the numbers and percentages are shown.